论文部分内容阅读
《中国中医药报》2016年11月9日讯:工业和信息化部、国家卫生计生委、国家食品药品监督管理总局等6部门联合发布《医药工业发展规划指南》,为“十三五”时期加快医药工业由大到强的转变明确方向。中药被列为发展重点领域之一,明确将针对中医优势病种开展复方、有效部位及有效成分中药重点品种研究,发展质量稳定可控、临床优势突出的现代中药。《指南》明确,到2020年,实现规模效益稳定增长,创新能力显著增强,产品质量全面提高,
“China’s Traditional Chinese Medicine Newspaper” November 9, 2016 hearing: The Ministry of Industry and Information Technology, the State Health and Family Planning Commission, the State Food and Drug Administration and other departments jointly issued six “guidelines for the development of the pharmaceutical industry,” for the “Thirteen Five ”Period to speed up the pharmaceutical industry from strong to strong change in a clear direction. Traditional Chinese medicine is listed as one of the key areas of development. It will explicitly study the key traditional Chinese medicines of compound prescriptions, effective sites and active ingredients for the predominance of TCM diseases, and develop modern Chinese medicines with stable and controlled quality and prominent clinical advantages. “Guide” clearly, by 2020, achieve the steady growth of scale and efficiency, significantly enhance the ability to innovate, improve the overall quality of products,